Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 8, 2012Clinical Pharmacology & Therapeutics

Alanine Aminotransferase: A Clinical and Regulatory Tool for Detecting Liver Injury–Past, Present, and Future

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJohn SeniorRutgers, The State University of New Jersey

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

John Senior (2012) studied this question.

synapsesocial.com/papers/69d77249db9d5e1bf4b8a9e6https://doi.org/10.1038/clpt.2012.108
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The existence of a relationship between increased serum alanine aminotransferase levels detected in premarketing clinical trials and postmarketing published hepatotoxicity case reports2010 · 19 citations
  2. 2Recommendations to Qualify Biomarker Candidates of Drug-Induced Liver Injury2010 · 19 citations
  3. 3The Spectrum of Hepatotoxicity1968 · 133 citations
  4. 4A Colorimetric Method for the Determination of Serum Glutamic Oxalacetic and Glutamic Pyruvic Transaminases1957 · 10,032 citations
  5. 5Why Are Clinical Laboratory Tests Performed? When Are They Valid?1975 · 65 citations